المؤلفون: Wallace DS; University of Rochester., Barr PM; University of Rochester.

المصدر: Blood [Blood] 2024 Aug 22; Vol. 144 (8), pp. 800-802.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE

مواضيع طبية MeSH: Adenine*/analogs & derivatives , Piperidines*/therapeutic use , Piperidines*/administration & dosage , Bridged Bicyclo Compounds, Heterocyclic*/therapeutic use , Bridged Bicyclo Compounds, Heterocyclic*/administration & dosage , Bridged Bicyclo Compounds, Heterocyclic*/pharmacology , Sulfonamides*/therapeutic use , Sulfonamides*/administration & dosage , Antineoplastic Combined Chemotherapy Protocols*/therapeutic use , Lymphoma, Mantle-Cell*/drug therapy , Lymphoma, Mantle-Cell*/pathology, Humans ; Pyrimidines/therapeutic use ; Pyrimidines/administration & dosage ; Pyrazoles/therapeutic use ; Pyrazoles/administration & dosage

المؤلفون: Durrani AF; Mid Atlantic Retina, Wills Eye Hospital, Philadelphia, Pennsylvania, USA., Momenaei B; Mid Atlantic Retina, Wills Eye Hospital, Philadelphia, Pennsylvania, USA., Wakabayashi T; Mid Atlantic Retina, Wills Eye Hospital, Philadelphia, Pennsylvania, USA., Vemula S; Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, Pennsylvania, USA., Pandit SA; Mid Atlantic Retina, Wills Eye Hospital, Philadelphia, Pennsylvania, USA., Hsu J; Mid Atlantic Retina, Wills Eye Hospital, Philadelphia, Pennsylvania, USA., Ho AC; Mid Atlantic Retina, Wills Eye Hospital, Philadelphia, Pennsylvania, USA., Spirn MJ; Mid Atlantic Retina, Wills Eye Hospital, Philadelphia, Pennsylvania, USA., Klufas MA; Mid Atlantic Retina, Wills Eye Hospital, Philadelphia, Pennsylvania, USA., Garg SJ; Mid Atlantic Retina, Wills Eye Hospital, Philadelphia, Pennsylvania, USA., Vander JF; Mid Atlantic Retina, Wills Eye Hospital, Philadelphia, Pennsylvania, USA., Regillo CD; Mid Atlantic Retina, Wills Eye Hospital, Philadelphia, Pennsylvania, USA., Chiang A; Mid Atlantic Retina, Wills Eye Hospital, Philadelphia, Pennsylvania, USA., Kuriyan AE; Mid Atlantic Retina, Wills Eye Hospital, Philadelphia, Pennsylvania, USA., Yonekawa Y; Mid Atlantic Retina, Wills Eye Hospital, Philadelphia, Pennsylvania, USA yyonekawa@midatlanticretina.com.

المصدر: The British journal of ophthalmology [Br J Ophthalmol] 2024 Aug 22; Vol. 108 (9), pp. 1257-1262. Date of Electronic Publication: 2024 Aug 22.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: BMJ Pub. Group Country of Publication: England NLM ID: 0421041 Publication Model: Electronic Cited Medium: Internet ISSN: 1468-2079 (Electronic) Linking ISSN: 00071161 NLM ISO Abbreviation: Br J Ophthalmol Subsets: MEDLINE

مواضيع طبية MeSH: Macular Edema*/drug therapy , Macular Edema*/etiology , Macular Edema*/physiopathology , Diabetic Retinopathy*/drug therapy , Diabetic Retinopathy*/physiopathology , Diabetic Retinopathy*/diagnosis , Angiogenesis Inhibitors*/therapeutic use , Angiogenesis Inhibitors*/administration & dosage , Intravitreal Injections* , Visual Acuity*/physiology , Vascular Endothelial Growth Factor A*/antagonists & inhibitors , Tomography, Optical Coherence* , Ranibizumab*/administration & dosage , Ranibizumab*/therapeutic use, Humans ; Male ; Female ; Aged ; Retrospective Studies ; Middle Aged ; Drug Substitution ; Bevacizumab/therapeutic use ; Bevacizumab/administration & dosage ; Receptors, Vascular Endothelial Growth Factor/therapeutic use ; Receptors, Vascular Endothelial Growth Factor/administration & dosage ; Treatment Outcome ; Follow-Up Studies

المؤلفون: Wu S; Department of Breast Oncology, The Fifth Medical Center of Chinese PLA General Hospital, No.8 East Street, Beijing, 100071, China., Bian L; Department of Breast Oncology, The Fifth Medical Center of Chinese PLA General Hospital, No.8 East Street, Beijing, 100071, China., Wang H; Breast Disease Center, The Affiliated Hospital of Qingdao University, Qingdao, China., Zhang S; Department of Breast Oncology, The Fifth Medical Center of Chinese PLA General Hospital, No.8 East Street, Beijing, 100071, China., Wang T; Department of Breast Oncology, The Fifth Medical Center of Chinese PLA General Hospital, No.8 East Street, Beijing, 100071, China., Yu Z; Department of Breast Surgery, The Second Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China., Li J; Department of Breast Oncology, The Fifth Medical Center of Chinese PLA General Hospital, No.8 East Street, Beijing, 100071, China., Li F; Department of Breast Oncology, The Fifth Medical Center of Chinese PLA General Hospital, No.8 East Street, Beijing, 100071, China., Wang K; Department of Breast Cancer, Cancer Center, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, No. 106 Zhongshan Second Road, Guangzhou, 510080, China. gzwangkun@126.com., Jiang Z; Department of Breast Oncology, The Fifth Medical Center of Chinese PLA General Hospital, No.8 East Street, Beijing, 100071, China. jiangzefei@csco.org.cn.

المصدر: World journal of surgical oncology [World J Surg Oncol] 2024 Aug 21; Vol. 22 (1), pp. 214. Date of Electronic Publication: 2024 Aug 21.

نوع المنشور: Journal Article; Multicenter Study

بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 101170544 Publication Model: Electronic Cited Medium: Internet ISSN: 1477-7819 (Electronic) Linking ISSN: 14777819 NLM ISO Abbreviation: World J Surg Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Breast Neoplasms*/drug therapy , Breast Neoplasms*/pathology , Breast Neoplasms*/metabolism , Neoadjuvant Therapy*/methods , Carboplatin*/administration & dosage , Antineoplastic Combined Chemotherapy Protocols*/therapeutic use , Receptor, ErbB-2*/metabolism , Taxoids*/administration & dosage, Humans ; Female ; Middle Aged ; China/epidemiology ; Adult ; Follow-Up Studies ; Trastuzumab/administration & dosage ; Trastuzumab/therapeutic use ; Prognosis ; Retrospective Studies ; Aged ; Bridged-Ring Compounds/administration & dosage ; Bridged-Ring Compounds/therapeutic use ; Antibodies, Monoclonal, Humanized/administration & dosage

المؤلفون: Liu Z; College of Biotechnology and Pharmaceutical Engineering, Nanjing Tech University, Nanjing 211816, China., Bai P; Nanjing Foreign Language School, Nanjing 210008, China., Wang L; College of Biotechnology and Pharmaceutical Engineering, Nanjing Tech University, Nanjing 211816, China., Zhu L; College of Chemical and Molecular Engineering, Nanjing Tech University, Nanjing 211816, China., Zhu Z; College of Food Science and Light Industry, Nanjing Tech University, Nanjing 211816, China., Jiang L; College of Food Science and Light Industry, Nanjing Tech University, Nanjing 211816, China.; State Key Laboratory of Materials-Oriented Chemical Engineering, Nanjing Tech University, Nanjing 211816, China.

المصدر: Journal of agricultural and food chemistry [J Agric Food Chem] 2024 Aug 21; Vol. 72 (33), pp. 18497-18506. Date of Electronic Publication: 2024 Aug 04.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: American Chemical Society Country of Publication: United States NLM ID: 0374755 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1520-5118 (Electronic) Linking ISSN: 00218561 NLM ISO Abbreviation: J Agric Food Chem Subsets: MEDLINE

مواضيع طبية MeSH: Gastrointestinal Microbiome*/drug effects , Oligosaccharides*/administration & dosage , Inflammatory Bowel Diseases*/microbiology , Inflammatory Bowel Diseases*/drug therapy , Inflammatory Bowel Diseases*/therapy , Inflammatory Bowel Diseases*/metabolism , Clostridium tyrobutyricum*/metabolism , Synbiotics*/administration & dosage, Animals ; Humans ; Mice ; Male ; Fatty Acids, Volatile/metabolism ; Mice, Inbred C57BL ; Probiotics/administration & dosage ; Probiotics/pharmacology ; Prebiotics/administration & dosage ; Chitosan

المؤلفون: Fang W; Sun Yat-sen University Cancer Center, Guangzhou, China., Zhao Y; Sun Yat-sen University Cancer Center, Guangzhou, China., Luo Y; Hunan Cancer Hospital, Changsha, China., Yang R; Yunnan Cancer Hospital, Kunming, China., Huang Y; Sun Yat-sen University Cancer Center, Guangzhou, China., He Z; Fujian Provincial Tumor Hospital, Fuzhou, China., Zhao H; The Second Hospital of Anhui Medical University, Hefei, China., Li M; The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China., Li K; Tianjin Medical University Cancer Institute & Hospital, Tianjin, China., Song Q; Renmin Hospital of Wuhan University, Wuhan, China., Du X; Mianyang Central Hospital, Mianyang, China., Sun Y; Shandong Cancer Prevention and Treatment Institute, Jinan, China., Li W; The First Affiliated Hospital of Bengbu Medical University, Bengbu, China., Xu F; The First Affiliated Hospital of Nanchang University, Nanchang, China., Wang Z; The Fourth Hospital of Hebei Medical University, Shijiazhuang, China., Yang K; Weifang No. 2 People's Hospital, Weifang, China., Fan Y; Zhejiang Cancer Hospital, Hangzhou, China., Liu B; Harbin Medical University Cancer Hospital, Harbin, China., Zhao H; Sun Yat-sen University Cancer Center, Guangzhou, China., Hu Y; Beijing Chest Hospital, Capital Medical University, Beijing, China., Jia L; Yuncheng Central Hospital of Shanxi Province, Yuncheng, China., Xu S; Zhangzhou Municipal Hospital of Fujian Province, Zhangzhou, China., Yi T; Xiangyang Central Hospital, Xiangyang, China., Lv D; Taizhou Municipal Hospital, Taizhou, China., Lan H; Sichuan Provincial People's Hospital, Chengdu, China., Li M; Army Medical Center of Chinese People's Liberation Army, Chongqing, China., Liang W; The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China., Wang Y; West China Hospital of Sichuan University, Chengdu, China., Yang H; The Second Affiliated Hospital of Xiamen Medical College, Xiamen, China., Jia Y; Yibin Second People's Hospital, Yibin, China., Chen Y; Tongji Hospital of Tongji Medical College of Hust, Wuhan, China., Lu J; Nantong Tumor Hospital, Nantong, China., Feng J; Jiangsu Cancer Hospital, Nanjing, China., Liu C; Affiliated Tumor Hospital of Xinjiang Medical University, Urumqi, China., Zhou M; Affiliated Cancer Hospital and Institution of Guangzhou Medical University, Guangzhou, China., Zhou J; The First Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China., Liu X; The Second Xiangya Hospital of Central South University, Changsha, China., Zhou N; Sun Yat-sen University Cancer Center, Guangzhou, China., He M; The Fourth Hospital of Hebei Medical University, Shijiazhuang, China., Dong X; Union Hospital Tongji Medical College Huazhong University of Science and Technology, Wuhan, China., Chen H; Affiliated Hospital of Guangdong Medical University, Guangzhou, China., Chen Y; Hainan General Hospital, Haikou, China., Su H; Tangdu Hospital of the Fourth Military Medical University, Xi'an, China., Li X; Liaoning Cancer Hospital & Institute, Cancer Hospital of Dalian University of Technology, Shenyang, China., Zhang Z; Anhui Provincial Cancer Hospital, Hefei, China., Yang L; Gansu Provincial Cancer Hospital, Lanzhou, China., Cheng Y; Jilin Cancer Hospital, Changchun, China., Chen L; Sun Yat-sen University Cancer Center, Guangzhou, China., Hou X; Sun Yat-sen University Cancer Center, Guangzhou, China., Zhang Y; Nanjing Chest Hospital, Nanjing, China., Guo J; Xingtai People's Hospital, Xingtai, China., Wang Z; Linyi Cancer Hospital, Linyi, China., Lu H; Huaihe Hospital of Henan University, Kaifeng, China., Wu D; Shenzhen Institute of Respiratory Diseases, Shenzhen People's Hospital (First Affiliated Hospital of Southern University of Science and Technology, Second Clinical Medical College of Jinan University), Shenzhen, China., Feng W; The First People's Hospital of Foshan, Foshan, China., Li W; The Second Affiliated Hospital Zhejiang University School of Medicine, Hangzhou, China., Huang J; The First Affiliated Hospital of Soochow University, Suzhou, China., Wang Y; General Hospital of Ningxia Medical University, Yinchuan, China., Song X; Shanxi Cancer Hospital, Taiyuan, China., Peng J; Zhongshan City People's Hospital, Zhongshan, China., Liu L; Nanfang Hospital Nanfang Medical University, Guangzhou, China., Guo Y; The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China., Li W; Akeso Biopharma, Inc, Zhongshan, China., Lu D; Akeso Biopharma, Inc, Zhongshan, China., Hu M; Akeso Biopharma, Inc, Zhongshan, China., Wang ZM; Akeso Biopharma, Inc, Zhongshan, China., Li B; Akeso Biopharma, Inc, Zhongshan, China., Xia M; Akeso Biopharma, Inc, Zhongshan, China., Zhang L; Sun Yat-sen University Cancer Center, Guangzhou, China.

مؤلفون مشاركون: HARMONi-A Study Investigators

المصدر: JAMA [JAMA] 2024 Aug 20; Vol. 332 (7), pp. 561-570.

نوع المنشور: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase III; Multicenter Study; Comparative Study

بيانات الدورية: Publisher: American Medical Association Country of Publication: United States NLM ID: 7501160 Publication Model: Print Cited Medium: Internet ISSN: 1538-3598 (Electronic) Linking ISSN: 00987484 NLM ISO Abbreviation: JAMA Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Combined Chemotherapy Protocols*/administration & dosage , Antineoplastic Combined Chemotherapy Protocols*/adverse effects , Carboplatin*/administration & dosage , Carboplatin*/adverse effects , Carcinoma, Non-Small-Cell Lung*/drug therapy , Carcinoma, Non-Small-Cell Lung*/genetics , Carcinoma, Non-Small-Cell Lung*/mortality , ErbB Receptors*/genetics , Lung Neoplasms*/drug therapy , Lung Neoplasms*/genetics , Lung Neoplasms*/mortality , Pemetrexed*/administration & dosage , Pemetrexed*/adverse effects , Progression-Free Survival*, Adult ; Aged ; Female ; Humans ; Male ; Middle Aged ; Antibodies, Monoclonal, Humanized/administration & dosage ; Antibodies, Monoclonal, Humanized/adverse effects ; Double-Blind Method ; Intention to Treat Analysis ; Mutation ; Antibodies, Bispecific/administration & dosage ; Antibodies, Bispecific/adverse effects

المؤلفون: Schneider BP; Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis, IN., Zhao F; Dana Farber Cancer Institute-ECOG-ACRIN Biostatistics Center, Boston, MA., Ballinger TJ; Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis, IN., Garcia SF; Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL., Shen F; Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis, IN., Virani S; Aurora Cancer Care-Southern Lakes VLCC, Burlington, WI., Cella D; Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL., Bales C; Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis, IN., Jiang G; Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis, IN., Hayes L; Pink-4-Ever Ending Disparities, Indianapolis, IN., Miller N; Pink-4-Ever Ending Disparities, Indianapolis, IN., Srinivasiah J; Georgia NCORP, Decatur, GA., Stringer-Reasor EM; University of Alabama at Birmingham O'Neal Comprehensive Cancer Center, Birmingham, AL., Chitalia A; MedStar Washington Hospital Center, Washington, DC., Davis AA; Washington University School of Medicine, St Louis, MO., Makower DF; Montefiore Medical Center-Weiler Hospital, New York, NY., Incorvati J; Fox Chase Comprehensive Cancer Center, Philadelphia, PA., Simon MA; Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL., Mitchell EP; Thomas Jefferson University Hospital, Philadelphia, PA.; Deceased, Baltimore, MD., DeMichele A; University of Pennsylvania, Philadelphia, PA., Miller KD; Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis, IN., Sparano JA; Icahn School of Medicine at Mount Sinai, Tisch Cancer Institute, New York, NY., Wagner LI; University of North Carolina, Chapel Hill, NC., Wolff AC; Johns Hopkins University/Sidney Kimmel Comprehensive Cancer Center.

المصدر: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2024 Aug 20; Vol. 42 (24), pp. 2899-2907. Date of Electronic Publication: 2024 Jun 03.

نوع المنشور: Journal Article; Validation Study

بيانات الدورية: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Breast Neoplasms*/drug therapy , Breast Neoplasms*/genetics , Peripheral Nervous System Diseases*/chemically induced , Peripheral Nervous System Diseases*/genetics , Paclitaxel*/administration & dosage , Paclitaxel*/adverse effects , Docetaxel*/administration & dosage , Docetaxel*/adverse effects , Black or African American*/genetics, Humans ; Female ; Middle Aged ; Prospective Studies ; Adult ; Aged ; Taxoids/adverse effects ; Taxoids/administration & dosage ; Neoplasm Staging ; Germ-Line Mutation ; Bridged-Ring Compounds/adverse effects ; Bridged-Ring Compounds/administration & dosage

المؤلفون: Denis L; Department of Clinical Pharmacy, Gustave Roussy Cancer Campus, 114 rue Edouard Vaillant 94800 Villejuif, France., Jørgensen AK; Department of Pharmaceutics, UCL School of Pharmacy, University College London, 29-39 Brunswick Square, London WC1N 1AX, UK., Do B; Department of Clinical Pharmacy, Gustave Roussy Cancer Campus, 114 rue Edouard Vaillant 94800 Villejuif, France; Institut des Sciences Moléculaires d'Orsay (ISMO), Université Paris-Saclay, CNRS, 91405 Orsay, France., Vaz-Luis I; Department of Medical Oncology, Gustave Roussy, Villejuif, France; Department for the Organization of Patient Pathways (DIOPP), Gustave Roussy, France; Unit INSERM 981 - Gustave Roussy, Villejuif, France., Pistilli B; Department of Medical Oncology, Gustave Roussy, Villejuif, France; Unit INSERM 1279, Gustave Roussy, Villejuif, France., Rieutord A; Department of Clinical Pharmacy, Gustave Roussy Cancer Campus, 114 rue Edouard Vaillant 94800 Villejuif, France., Basit AW; Department of Pharmaceutics, UCL School of Pharmacy, University College London, 29-39 Brunswick Square, London WC1N 1AX, UK; FABRX Ltd., Henwood House, Henwood, Ashford TN24 8DH, UK; Departamento de Farmacología, Farmacia y Tecnología Farmacéutica, I+D Farma (GI-1645), Facultad de Farmacia, Instituto de Materiales (iMATUS) and Health Research Institute of Santiago de Compostela (IDIS), Universidade de Santiago de Compostela, 15782 Santiago de Compostela, Spain., Goyanes A; Department of Pharmaceutics, UCL School of Pharmacy, University College London, 29-39 Brunswick Square, London WC1N 1AX, UK; FABRX Artificial Intelligence, Carretera de Escairón, 14, Currelos (O Saviñao), CP 27543, Spain; FABRX Ltd., Henwood House, Henwood, Ashford TN24 8DH, UK; Departamento de Farmacología, Farmacia y Tecnología Farmacéutica, I+D Farma (GI-1645), Facultad de Farmacia, Instituto de Materiales (iMATUS) and Health Research Institute of Santiago de Compostela (IDIS), Universidade de Santiago de Compostela, 15782 Santiago de Compostela, Spain., Annereau M; Department of Clinical Pharmacy, Gustave Roussy Cancer Campus, 114 rue Edouard Vaillant 94800 Villejuif, France; Institut des Sciences Moléculaires d'Orsay (ISMO), Université Paris-Saclay, CNRS, 91405 Orsay, France. Electronic address: maxime.annereau@gustaveroussy.fr.

المصدر: International journal of pharmaceutics [Int J Pharm] 2024 Aug 15; Vol. 661, pp. 124306. Date of Electronic Publication: 2024 Jun 11.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier/North-Holland Biomedical Press Country of Publication: Netherlands NLM ID: 7804127 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-3476 (Electronic) Linking ISSN: 03785173 NLM ISO Abbreviation: Int J Pharm Subsets: MEDLINE

مواضيع طبية MeSH: Printing, Three-Dimensional* , Tamoxifen*/administration & dosage , Duloxetine Hydrochloride*/administration & dosage , Precision Medicine*/methods , Venlafaxine Hydrochloride*/administration & dosage , Breast Neoplasms*/drug therapy, Humans ; Female ; Antidepressive Agents/administration & dosage ; Drug Compounding/methods ; Antineoplastic Agents, Hormonal/administration & dosage

المؤلفون: Chen X; Department of Anaesthesiology, The First College of Clinical Medical Science, China Three Gorges University & Yichang Central People's Hospital, Xiling District, No. 4, Hudi Street, Yichang, 443000, China., Han M; Department of Anaesthesiology, The First College of Clinical Medical Science, China Three Gorges University & Yichang Central People's Hospital, Xiling District, No. 4, Hudi Street, Yichang, 443000, China., Shu A; Department of Anaesthesiology, The First College of Clinical Medical Science, China Three Gorges University & Yichang Central People's Hospital, Xiling District, No. 4, Hudi Street, Yichang, 443000, China., Zhou M; Department of Anaesthesiology, The First College of Clinical Medical Science, China Three Gorges University & Yichang Central People's Hospital, Xiling District, No. 4, Hudi Street, Yichang, 443000, China., Wang K; Department of Anaesthesiology, The First College of Clinical Medical Science, China Three Gorges University & Yichang Central People's Hospital, Xiling District, No. 4, Hudi Street, Yichang, 443000, China., Cheng C; Department of Anaesthesiology, The First College of Clinical Medical Science, China Three Gorges University & Yichang Central People's Hospital, Xiling District, No. 4, Hudi Street, Yichang, 443000, China. chuanxi1991@163.com.

المصدر: BMC anesthesiology [BMC Anesthesiol] 2024 Aug 13; Vol. 24 (1), pp. 290. Date of Electronic Publication: 2024 Aug 13.

نوع المنشور: Journal Article; Randomized Controlled Trial

بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 100968535 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2253 (Electronic) Linking ISSN: 14712253 NLM ISO Abbreviation: BMC Anesthesiol Subsets: MEDLINE

مواضيع طبية MeSH: Alfentanil*/administration & dosage , Alfentanil*/pharmacology , Heart Rate*/drug effects , Propofol*/administration & dosage , Propofol*/pharmacology , Rapid Sequence Induction and Intubation*/methods , Dose-Response Relationship, Drug*, Humans ; Aged ; Male ; Female ; Aged, 80 and over ; Anesthetics, Intravenous/administration & dosage ; Anesthetics, Intravenous/pharmacology ; Etomidate/administration & dosage ; Etomidate/pharmacology ; Intubation, Intratracheal/methods ; Blood Pressure/drug effects ; Anesthesia, General/methods

المؤلفون: He Q; School of Medicine and Pharmacy, Ocean University of China, Key Laboratory of Marine Drugs, MOE, Qingdao, 266003, China; National Engineering Research Center of Immunological Products, Department of Microbiology and Biochemical Pharmacy, College of Pharmacy, Army Medical University, Chongqing 400038, China., Chen Y; National Engineering Research Center of Immunological Products, Department of Microbiology and Biochemical Pharmacy, College of Pharmacy, Army Medical University, Chongqing 400038, China., Li Y; National Engineering Research Center of Immunological Products, Department of Microbiology and Biochemical Pharmacy, College of Pharmacy, Army Medical University, Chongqing 400038, China., Cheng X; National Engineering Research Center of Immunological Products, Department of Microbiology and Biochemical Pharmacy, College of Pharmacy, Army Medical University, Chongqing 400038, China., Li X; Department of Geriatrics, People's Liberation Army The General Hospital of Western Theater Command, Chengdu 610083, China., Wu M; National Engineering Research Center of Immunological Products, Department of Microbiology and Biochemical Pharmacy, College of Pharmacy, Army Medical University, Chongqing 400038, China., Wan J; National Engineering Research Center of Immunological Products, Department of Microbiology and Biochemical Pharmacy, College of Pharmacy, Army Medical University, Chongqing 400038, China., Luo P; National Engineering Research Center of Immunological Products, Department of Microbiology and Biochemical Pharmacy, College of Pharmacy, Army Medical University, Chongqing 400038, China., Wang Y; School of Medicine and Pharmacy, Ocean University of China, Key Laboratory of Marine Drugs, MOE, Qingdao, 266003, China. Electronic address: wangyi0213@ouc.edu.cn., Gu J; National Engineering Research Center of Immunological Products, Department of Microbiology and Biochemical Pharmacy, College of Pharmacy, Army Medical University, Chongqing 400038, China. Electronic address: jianggu2012@163.com., Zhang Y; National Engineering Research Center of Immunological Products, Department of Microbiology and Biochemical Pharmacy, College of Pharmacy, Army Medical University, Chongqing 400038, China. Electronic address: zhangyusmile@163.com.

المصدر: Vaccine [Vaccine] 2024 Aug 13; Vol. 42 (20), pp. 125976. Date of Electronic Publication: 2024 May 31.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 8406899 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-2518 (Electronic) Linking ISSN: 0264410X NLM ISO Abbreviation: Vaccine Subsets: MEDLINE

مواضيع طبية MeSH: Nanovaccines*/administration & dosage , Nanovaccines*/immunology , Tetanus*/prevention & control , Tetanus*/immunology , Tetanus Toxin*/immunology , Tetanus Toxin*/genetics , Tetanus Toxoid*/immunology , Tetanus Toxoid*/administration & dosage, Animals ; Female ; Mice ; Antibodies, Bacterial/blood ; Antibodies, Bacterial/immunology ; Mice, Inbred BALB C ; Nanoparticles/chemistry ; Peptide Fragments/immunology ; Peptide Fragments/administration & dosage ; Vaccines, Subunit/immunology ; Vaccines, Subunit/administration & dosage ; Vaccines, Synthetic/immunology ; Vaccines, Synthetic/administration & dosage

المؤلفون: Machida M; Department of Preventive Medicine and Public Health, Tokyo Medical University, 6-1-1 Shinjuku, Shinjuku-ku, Tokyo 160-8402, Japan; Department of Infection Prevention and Control, Tokyo Medical University Hospital, 6-7-1 Nishishinjuku, Shinjuku-ku, Tokyo 160-0023, Japan. Electronic address: machida@tokyo-med.ac.jp., Fukushima S; Travellers' Medical Center, Tokyo Medical University Hospital, 6-7-1 Nishishinjuku, Shinjuku-ku, Tokyo 160-0023, Japan. Electronic address: fuku789@tokyo-med.ac.jp., Saitoh A; Department of Pediatrics, Niigata University Graduate School of Medical and Dental Sciences, 1-757 Asahimachi-dori, Chuo-ku, Niigata 951-8510, Japan. Electronic address: asaitoh@med.niigata-u.ac.jp., Inoue S; Department of Preventive Medicine and Public Health, Tokyo Medical University, 6-1-1 Shinjuku, Shinjuku-ku, Tokyo 160-8402, Japan. Electronic address: inoue@tokyo-med.ac.jp., Tabuchi T; Cancer Control Center, Osaka International Cancer Institute, 3-1-69 Otemae, Chuo-ku, Osaka, Osaka 541-5867, Japan; The Tokyo Foundation for Policy Research, Roppongi Grand Tower 34F, 3-2-1 Roppongi, Minato-ku, Tokyo 106-6234, Japan; Division of Epidemiology, School of Public Health, Tohoku University Graduate School of Medicine, 2-1, Seiryo-Machi, Aoba-Ku, Sendai, Miyagi 980-8575, Japan. Electronic address: takahiro.tabuchi.a5@tohoku.ac.jp.

المصدر: Vaccine [Vaccine] 2024 Aug 13; Vol. 42 (20), pp. 125985. Date of Electronic Publication: 2024 May 21.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 8406899 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-2518 (Electronic) Linking ISSN: 0264410X NLM ISO Abbreviation: Vaccine Subsets: MEDLINE

مواضيع طبية MeSH: Influenza Vaccines*/administration & dosage , Vaccination*/statistics & numerical data , Pneumococcal Vaccines*/administration & dosage, Humans ; Aged ; Japan ; Male ; Female ; Aged, 80 and over ; Surveys and Questionnaires ; COVID-19/prevention & control ; COVID-19/epidemiology ; Herpes Zoster Vaccine/administration & dosage ; Herpes Zoster Vaccine/immunology ; COVID-19 Vaccines/administration & dosage ; Immunization Schedule ; Vaccination Coverage/statistics & numerical data ; SARS-CoV-2/immunology